Dmytro Kharkov

Zevra Therapeutics CEO to present company updates at H.C. Wainwright BioConnect Investor Conference

Zevra Therapeutics CEO to present company updates at H.C. Wainwright BioConnect Investor Conference
Zevra Therapeutics CEO to present

Zevra Therapeutics has announced that its President and CEO, Neil McFarlane, will share the latest updates about the company during a fireside chat at the H.C. Wainwright BioConnect Investor Conference. The session is scheduled for Tuesday, May 19, 2026, at 9:30 am ET.

The presentation will be available via webcast for investors and stakeholders seeking insights into the company’s recent activities and outlook. Registration for the webcast is open to the public.

Earlier this month, Zevra Therapeutics held a webcast to discuss its first quarter 2026 results and provide a corporate update. The company also presented results from its NPC002 trial and genotype analysis for Niemann-Pick disease at SIMD2026 on May 18. These events come as Zevra shares its latest developments with investors at the H.C. Wainwright conference.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.